{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:51:53Z","timestamp":1790268713484,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.canlet.2022.215930","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T11:59:35Z","timestamp":1664452775000},"page":"215930","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["DANCR deletion retards the initiation and progression of hepatocellular carcinoma based on gene knockout and patient-derived xenograft in situ hepatoma mice model"],"prefix":"10.1016","volume":"550","author":[{"given":"Xiaojie","family":"Gan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengchao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dapeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengxian","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2022.215930_bib1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1053\/j.gastro.2020.02.068","article-title":"Global burden of 5 major types of gastrointestinal cancer","volume":"159","author":"Arnold","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2022.215930_bib2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"Association for the study of the liver. Electronic address, L. European association for the study of the, EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","author":"European","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2022.215930_bib3","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"Suppl 1","key":"10.1016\/j.canlet.2022.215930_bib4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/hep.31325","article-title":"Surgical treatments of hepatobiliary cancers","volume":"73","author":"Gunasekaran","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2022.215930_bib5","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2022.215930_bib6","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S1470-2045(21)00151-0","article-title":"Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial","volume":"22","author":"Galle","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2022.215930_bib7","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202009045","article-title":"LNCcation: lncRNA localization and function","volume":"220","author":"Bridges","year":"2021","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.canlet.2022.215930_bib8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.molmed.2018.01.001","article-title":"Therapeutic targeting of long non-coding RNAs in cancer","volume":"24","author":"Arun","year":"2018","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.canlet.2022.215930_bib9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41568-020-00306-0","article-title":"RNA in cancer","volume":"21","author":"Goodall","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2022.215930_bib10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/cac2.12108","article-title":"LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer","volume":"41","author":"Tan","year":"2021","journal-title":"Cancer Commun."},{"key":"10.1016\/j.canlet.2022.215930_bib11","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41573-021-00219-z","article-title":"Noncoding RNA therapeutics - challenges and potential solutions","volume":"20","author":"Winkle","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2022.215930_bib12","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1038\/onc.2017.88","article-title":"Oncogenic effects of evolutionarily conserved noncoding RNA ECONEXIN on gliomagenesis","volume":"36","author":"Deguchi","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2022.215930_bib13","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.cell.2017.11.040","article-title":"Oncogenic role of THOR, a conserved cancer\/testis long non-coding RNA","volume":"171","author":"Hosono","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2022.215930_bib14","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells","volume":"411","author":"Elbashir","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2022.215930_bib15","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.biotechadv.2019.04.012","article-title":"RNAi therapeutic and its innovative biotechnological evolution","volume":"37","author":"Weng","year":"2019","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.canlet.2022.215930_bib16","first-page":"4953","article-title":"miR215p ameliorates hyperoxic acute lung injury and decreases apoptosis of AEC II cells via PTEN\/AKT signaling in rats","volume":"20","author":"Qin","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.canlet.2022.215930_bib17","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41419-020-02872-5","article-title":"ASF1B promotes cervical cancer progression through stabilization of CDK9","volume":"11","author":"Liu","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2022.215930_bib18","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/hep.27893","article-title":"Long noncoding RNA DANCR increases stemness features of hepatocellular carcinoma by derepression of CTNNB1","volume":"63","author":"Yuan","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2022.215930_bib19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jhep.2015.01.036","article-title":"beta-PDGF receptor expressed by hepatic stellate cells regulates fibrosis in murine liver injury, but not carcinogenesis","volume":"63","author":"Kocabayoglu","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2022.215930_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/toxsci\/kfs342","article-title":"Molecular mechanisms of fibrosis-associated promotion of liver carcinogenesis","volume":"132","author":"Uehara","year":"2013","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.canlet.2022.215930_bib21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-1-61779-005-8_7","article-title":"High-resolution fluorescence in situ hybridization to detect mRNAs in neuronal compartments in vitro and in vivo","volume":"714","author":"Swanger","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.canlet.2022.215930_bib22","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E","article-title":"Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies","volume":"7","author":"Edmondson","year":"1954","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2022.215930_bib23","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/nm1663","article-title":"TLR4 enhances TGF-beta signaling and hepatic fibrosis","volume":"13","author":"Seki","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2022.215930_bib24","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1475-2875-6-169","article-title":"Improved isolation of murine hepatocytes for in vitro malaria liver stage studies","volume":"6","author":"Goncalves","year":"2007","journal-title":"Malar. J."},{"key":"10.1016\/j.canlet.2022.215930_bib25","doi-asserted-by":"crossref","first-page":"6389","DOI":"10.21873\/anticanres.11236","article-title":"DANCR acts as a diagnostic biomarker and promotes tumor growth and metastasis in hepatocellular carcinoma","volume":"36","author":"Ma","year":"2016","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2022.215930_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12628","article-title":"DANCR promotes HCC progression and regulates EMT by sponging miR-27a-3p via ROCK1\/LIMK1\/COFILIN1 pathway","volume":"52","author":"Guo","year":"2019","journal-title":"Cell Prolif"},{"key":"10.1016\/j.canlet.2022.215930_bib27","doi-asserted-by":"crossref","first-page":"9408","DOI":"10.1002\/jcp.27625","article-title":"DANCR contributed to hepatocellular carcinoma malignancy via sponging miR-216a-5p and modulating KLF12","volume":"234","author":"Wang","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.canlet.2022.215930_bib28","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.2147\/OTT.S229957","article-title":"LncRNA DANCR promotes sorafenib resistance via activation of IL-6\/STAT3 signaling in hepatocellular carcinoma cells","volume":"13","author":"Liu","year":"2020","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.canlet.2022.215930_bib29","first-page":"8778","article-title":"LncRNA DANCR promotes ATG7 expression to accelerate hepatocellular carcinoma cell proliferation and autophagy by sponging miR-222-3p","volume":"24","author":"Wang","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.canlet.2022.215930_bib30","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1177\/0300891620977010","article-title":"Crosstalk between lncRNA DANCR and miR-125b-5p in HCC cell progression","volume":"107","author":"Yang","year":"2021","journal-title":"Tumori"},{"key":"10.1016\/j.canlet.2022.215930_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003231","article-title":"Immuno-oncology trends: preclinical models, biomarkers, and clinical development","volume":"10","author":"Franklin","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2022.215930_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.658399","article-title":"Anti-AAV antibodies in AAV gene therapy: current challenges and possible solutions","volume":"12","author":"Weber","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2022.215930_bib33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-61779-370-7_6","article-title":"AAV-mediated liver-directed gene therapy","volume":"807","author":"Sands","year":"2011","journal-title":"Methods Mol. Biol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383522004177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383522004177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T16:07:24Z","timestamp":1759594044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383522004177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":33,"alternative-id":["S0304383522004177"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2022.215930","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DANCR deletion retards the initiation and progression of hepatocellular carcinoma based on gene knockout and patient-derived xenograft in situ hepatoma mice model","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2022.215930","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"215930"}}